With prostate cancer trial done, Peninsula drug maker will ask for FDA approval
Myovant Sciences also will seek FDA approval next year of a different version of the same drug to treat heavy menstrual bleeding in women with uterine fibroids.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news
More News: Biotechnology | Bleeding | Cancer | Cancer & Oncology | Cancer of the Uterus | Health Management | Men | Prostate Cancer | Women